Correlation of CD44v6 expression with ovarian cancer progression and recurrence
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correlation of CD44v6 expression with ovarian cancer progression and recurrence ; volume:13 ; number:1 ; day:8 ; month:4 ; year:2013 ; pages:1-10 ; date:12.2013
BMC cancer ; 13, Heft 1 (8.4.2013), 1-10, 12.2013
- Urheber
-
Shi, Jun
- Beteiligte Personen und Organisationen
-
Zhou, Zhou
Di, Wen
Li, Ningli
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-182
- URN
-
urn:nbn:de:1111-2016030410360
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shi, Jun
- Zhou, Zhou
- Di, Wen
- Li, Ningli
- SpringerLink (Online service)
Ähnliche Objekte (12)
Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
Increased RHAMM expression relates to ovarian cancer progression
Correlation study of NF-κB, IER3, and Recurrence of Ovarian Endometrioid Cysts
Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma
Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression
The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence
MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression
Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation
Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer
An integrative model for recurrence in ovarian cancer
Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
Increased RHAMM expression relates to ovarian cancer progression
Correlation study of NF-κB, IER3, and Recurrence of Ovarian Endometrioid Cysts
Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma
Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression
The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence
MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression
Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation
Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer
An integrative model for recurrence in ovarian cancer
Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
Increased RHAMM expression relates to ovarian cancer progression
Correlation study of NF-κB, IER3, and Recurrence of Ovarian Endometrioid Cysts
Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma
Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression
The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence
MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression
Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation
Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer